TY - JOUR
T1 - Electrophysiologic effects of ketanserin on canine Purkinje fibers, ventricular myocardium and the intact heart
AU - Zaza, A.
AU - Malfatto, G.
AU - Rosen, M. R.
PY - 1989
Y1 - 1989
N2 - We studied the actions of ketanserin (KT) on transmembrane action potentials (AP) of canine Purkinje fibers (PF) and ventricular muscle (VM) and on rhythm in vivo. PF AP duration (APD) was increased by KT (10-8 to 10-6 M) and shortened at 10-5 M. KT effect on APD was greater during stimulation at longer cycle lengths and KT induced early afterdepolarizations in two of six PF at [K+](o) = 2.7 mM. Maximum diastolic potential, AP amplitude and V̇(max) were not changed by KT. In VM, KT (10-8 to 10-6 M) prolonged APD; but 10-5 M KT did not shorten APD, reducing the difference in APD between VM and PF. KT had no effect on slow response V̇(max) or amplitude but prolonged APD. To analyze whether changes in Na plateau current or transient outward current contributed to KT effects on APD, we used tetrodotoxin (TTX) and 4-aminopyridine. TTX shortened APD and in this presence, KT (10-5 M) induced no further shortening. In contrast, the effect of KT persisted in the presence of 4-aminopyridine. In six anesthetized, open chest dogs, KT prolonged the QT interval, but did not modify QRS duration and epicardial conduction time or induce arrhythmias. KT facilitated the onset of torsades de pointes during epicardial aconitine application. We conclude: 1) KT (≤10-6 M) has 'Class III' antiarrhythmic properties and at higher concentrations decreases APD; 2) potentially arrhythmogenic effects of KT are EAD induction and altered dispersion of repolarization; 3) an action of TTX-sensitive plateau currents contributes to the effect of high doses of KT on repolarization and; 4) in vivo, KT prolonges the QT interval and, although not directly arrhythmogenic, can facilitate torsades de pointes.
AB - We studied the actions of ketanserin (KT) on transmembrane action potentials (AP) of canine Purkinje fibers (PF) and ventricular muscle (VM) and on rhythm in vivo. PF AP duration (APD) was increased by KT (10-8 to 10-6 M) and shortened at 10-5 M. KT effect on APD was greater during stimulation at longer cycle lengths and KT induced early afterdepolarizations in two of six PF at [K+](o) = 2.7 mM. Maximum diastolic potential, AP amplitude and V̇(max) were not changed by KT. In VM, KT (10-8 to 10-6 M) prolonged APD; but 10-5 M KT did not shorten APD, reducing the difference in APD between VM and PF. KT had no effect on slow response V̇(max) or amplitude but prolonged APD. To analyze whether changes in Na plateau current or transient outward current contributed to KT effects on APD, we used tetrodotoxin (TTX) and 4-aminopyridine. TTX shortened APD and in this presence, KT (10-5 M) induced no further shortening. In contrast, the effect of KT persisted in the presence of 4-aminopyridine. In six anesthetized, open chest dogs, KT prolonged the QT interval, but did not modify QRS duration and epicardial conduction time or induce arrhythmias. KT facilitated the onset of torsades de pointes during epicardial aconitine application. We conclude: 1) KT (≤10-6 M) has 'Class III' antiarrhythmic properties and at higher concentrations decreases APD; 2) potentially arrhythmogenic effects of KT are EAD induction and altered dispersion of repolarization; 3) an action of TTX-sensitive plateau currents contributes to the effect of high doses of KT on repolarization and; 4) in vivo, KT prolonges the QT interval and, although not directly arrhythmogenic, can facilitate torsades de pointes.
UR - http://www.scopus.com/inward/record.url?scp=0024409290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024409290&partnerID=8YFLogxK
M3 - Article
C2 - 2746507
AN - SCOPUS:0024409290
VL - 250
SP - 397
EP - 405
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
SN - 0022-3565
IS - 1
ER -